OrsoBio, Inc. — Form D
OrsoBio, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-13. The offering totals $84.6M, of which $84.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-13
- Form: D
- Accession: 0002000354-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $84.6M
- Amount sold: $84.6M
- Investors: 6
- Date of first sale: 2023-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-497033
Issuer
- Name: OrsoBio, Inc.
- CIK: 0002000354
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 101 JEFFERSON DR 1ST FLOOR STE 124, MENLO PARK, CA, 94025
- Phone: 650-208-8348
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Matthew Young | Director | Jupiter, FL |
| Evan Rachlin | Director | San Diego, CA |
| Srinivas Akkaraju | Director | Palo Alto, CA |
| Gangadhara Ganapati | Director | Palo Alto, CA |
| Gangadhara Ganapati | Executive Officer | Palo Alto, CA |
| Muzammil Mansuri | Director | New York, NY |
| Mani Subramanian | Director | MENLO PARK, CA |
| Mani Subramanian | Executive Officer | MENLO PARK, CA |
| Cory Freedland | Director | MENLO PARK, CA |
| Edward Fleming | Director | MENLO PARK, CA |
Other filings by this issuer (1)
More